img

Global Disease-Modifying Antirheumatic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Disease-Modifying Antirheumatic Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

It refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.
Disease-Modifying Antirheumatic Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Disease-Modifying Antirheumatic Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pharmaceutical Industry and Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Disease-Modifying Antirheumatic Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Disease-Modifying Antirheumatic Drug key manufacturers include AbbVie, Amgen, Pfizer, Roche Holding AG, Novartis International AG, Johnson & Johnson, Bristol-Myers Squibb, Merck and UCB S.A., etc. AbbVie, Amgen, Pfizer are top 3 players and held % sales share in total in 2022.
Disease-Modifying Antirheumatic Drug can be divided into Non-Steroidal Anti-Inflammatory Drugs, Steroidal Anti-Inflammatory Drugs, Slow Acting Drug and Immunological Preparation, etc. Non-Steroidal Anti-Inflammatory Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Disease-Modifying Antirheumatic Drug is widely used in various fields, such as Pharmaceutical Industry, Hospital and Clinic and Other,, etc. Pharmaceutical Industry provides greatest supports to the Disease-Modifying Antirheumatic Drug industry development. In 2022, global % sales of Disease-Modifying Antirheumatic Drug went into Pharmaceutical Industry filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Disease-Modifying Antirheumatic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie
Amgen
Pfizer
Roche Holding AG
Novartis International AG
Johnson & Johnson
Bristol-Myers Squibb
Merck
UCB S.A.
Eli Lilly and Company
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Steroidal Anti-Inflammatory Drugs
Slow Acting Drug
Immunological Preparation

Segment by Application


Pharmaceutical Industry
Hospital and Clinic
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Disease-Modifying Antirheumatic Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Disease-Modifying Antirheumatic Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Disease-Modifying Antirheumatic Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Disease-Modifying Antirheumatic Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Disease-Modifying Antirheumatic Drug introduction, etc. Disease-Modifying Antirheumatic Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Disease-Modifying Antirheumatic Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Disease-Modifying Antirheumatic Drug Market Overview
1.1 Disease-Modifying Antirheumatic Drug Product Overview
1.2 Disease-Modifying Antirheumatic Drug Market Segment by Type
1.2.1 Non-Steroidal Anti-Inflammatory Drugs
1.2.2 Steroidal Anti-Inflammatory Drugs
1.2.3 Slow Acting Drug
1.2.4 Immunological Preparation
1.3 Global Disease-Modifying Antirheumatic Drug Market Size by Type
1.3.1 Global Disease-Modifying Antirheumatic Drug Market Size Overview by Type (2024-2034)
1.3.2 Global Disease-Modifying Antirheumatic Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global Disease-Modifying Antirheumatic Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Disease-Modifying Antirheumatic Drug Sales Breakdown by Type (2024-2024)
2 Global Disease-Modifying Antirheumatic Drug Market Competition by Company
2.1 Global Top Players by Disease-Modifying Antirheumatic Drug Sales (2024-2024)
2.2 Global Top Players by Disease-Modifying Antirheumatic Drug Revenue (2024-2024)
2.3 Global Top Players by Disease-Modifying Antirheumatic Drug Price (2024-2024)
2.4 Global Top Manufacturers Disease-Modifying Antirheumatic Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Disease-Modifying Antirheumatic Drug Market Competitive Situation and Trends
2.5.1 Disease-Modifying Antirheumatic Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Disease-Modifying Antirheumatic Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Disease-Modifying Antirheumatic Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Disease-Modifying Antirheumatic Drug Market
2.8 Key Manufacturers Disease-Modifying Antirheumatic Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Disease-Modifying Antirheumatic Drug Status and Outlook by Region
3.1 Global Disease-Modifying Antirheumatic Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Disease-Modifying Antirheumatic Drug Historic Market Size by Region
3.2.1 Global Disease-Modifying Antirheumatic Drug Sales in Volume by Region (2024-2024)
3.2.2 Global Disease-Modifying Antirheumatic Drug Sales in Value by Region (2024-2024)
3.2.3 Global Disease-Modifying Antirheumatic Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Disease-Modifying Antirheumatic Drug Forecasted Market Size by Region
3.3.1 Global Disease-Modifying Antirheumatic Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Disease-Modifying Antirheumatic Drug Sales in Value by Region (2024-2034)
3.3.3 Global Disease-Modifying Antirheumatic Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Disease-Modifying Antirheumatic Drug by Application
4.1 Disease-Modifying Antirheumatic Drug Market Segment by Application
4.1.1 Pharmaceutical Industry
4.1.2 Hospital and Clinic
4.1.3 Other
4.2 Global Disease-Modifying Antirheumatic Drug Market Size by Application
4.2.1 Global Disease-Modifying Antirheumatic Drug Market Size Overview by Application (2024-2034)
4.2.2 Global Disease-Modifying Antirheumatic Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global Disease-Modifying Antirheumatic Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Disease-Modifying Antirheumatic Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe Disease-Modifying Antirheumatic Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Disease-Modifying Antirheumatic Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Disease-Modifying Antirheumatic Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Disease-Modifying Antirheumatic Drug Sales Breakdown by Application (2024-2024)
5 North America Disease-Modifying Antirheumatic Drug by Country
5.1 North America Disease-Modifying Antirheumatic Drug Historic Market Size by Country
5.1.1 North America Disease-Modifying Antirheumatic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Disease-Modifying Antirheumatic Drug Sales in Volume by Country (2024-2024)
5.1.3 North America Disease-Modifying Antirheumatic Drug Sales in Value by Country (2024-2024)
5.2 North America Disease-Modifying Antirheumatic Drug Forecasted Market Size by Country
5.2.1 North America Disease-Modifying Antirheumatic Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Disease-Modifying Antirheumatic Drug Sales in Value by Country (2024-2034)
6 Europe Disease-Modifying Antirheumatic Drug by Country
6.1 Europe Disease-Modifying Antirheumatic Drug Historic Market Size by Country
6.1.1 Europe Disease-Modifying Antirheumatic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Disease-Modifying Antirheumatic Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe Disease-Modifying Antirheumatic Drug Sales in Value by Country (2024-2024)
6.2 Europe Disease-Modifying Antirheumatic Drug Forecasted Market Size by Country
6.2.1 Europe Disease-Modifying Antirheumatic Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Disease-Modifying Antirheumatic Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Disease-Modifying Antirheumatic Drug by Region
7.1 Asia-Pacific Disease-Modifying Antirheumatic Drug Historic Market Size by Region
7.1.1 Asia-Pacific Disease-Modifying Antirheumatic Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Disease-Modifying Antirheumatic Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Disease-Modifying Antirheumatic Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Disease-Modifying Antirheumatic Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Disease-Modifying Antirheumatic Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Disease-Modifying Antirheumatic Drug Sales in Value by Region (2024-2034)
8 Latin America Disease-Modifying Antirheumatic Drug by Country
8.1 Latin America Disease-Modifying Antirheumatic Drug Historic Market Size by Country
8.1.1 Latin America Disease-Modifying Antirheumatic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Disease-Modifying Antirheumatic Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America Disease-Modifying Antirheumatic Drug Sales in Value by Country (2024-2024)
8.2 Latin America Disease-Modifying Antirheumatic Drug Forecasted Market Size by Country
8.2.1 Latin America Disease-Modifying Antirheumatic Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Disease-Modifying Antirheumatic Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Disease-Modifying Antirheumatic Drug by Country
9.1 Middle East and Africa Disease-Modifying Antirheumatic Drug Historic Market Size by Country
9.1.1 Middle East and Africa Disease-Modifying Antirheumatic Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Disease-Modifying Antirheumatic Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Disease-Modifying Antirheumatic Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Disease-Modifying Antirheumatic Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Disease-Modifying Antirheumatic Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Disease-Modifying Antirheumatic Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 AbbVie Disease-Modifying Antirheumatic Drug Products Offered
10.1.5 AbbVie Recent Development
10.2 Amgen
10.2.1 Amgen Company Information
10.2.2 Amgen Introduction and Business Overview
10.2.3 Amgen Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Amgen Disease-Modifying Antirheumatic Drug Products Offered
10.2.5 Amgen Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Pfizer Disease-Modifying Antirheumatic Drug Products Offered
10.3.5 Pfizer Recent Development
10.4 Roche Holding AG
10.4.1 Roche Holding AG Company Information
10.4.2 Roche Holding AG Introduction and Business Overview
10.4.3 Roche Holding AG Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Roche Holding AG Disease-Modifying Antirheumatic Drug Products Offered
10.4.5 Roche Holding AG Recent Development
10.5 Novartis International AG
10.5.1 Novartis International AG Company Information
10.5.2 Novartis International AG Introduction and Business Overview
10.5.3 Novartis International AG Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Novartis International AG Disease-Modifying Antirheumatic Drug Products Offered
10.5.5 Novartis International AG Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Johnson & Johnson Disease-Modifying Antirheumatic Drug Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Bristol-Myers Squibb
10.7.1 Bristol-Myers Squibb Company Information
10.7.2 Bristol-Myers Squibb Introduction and Business Overview
10.7.3 Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Products Offered
10.7.5 Bristol-Myers Squibb Recent Development
10.8 Merck
10.8.1 Merck Company Information
10.8.2 Merck Introduction and Business Overview
10.8.3 Merck Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Merck Disease-Modifying Antirheumatic Drug Products Offered
10.8.5 Merck Recent Development
10.9 UCB S.A.
10.9.1 UCB S.A. Company Information
10.9.2 UCB S.A. Introduction and Business Overview
10.9.3 UCB S.A. Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2024-2024)
10.9.4 UCB S.A. Disease-Modifying Antirheumatic Drug Products Offered
10.9.5 UCB S.A. Recent Development
10.10 Eli Lilly and Company
10.10.1 Eli Lilly and Company Company Information
10.10.2 Eli Lilly and Company Introduction and Business Overview
10.10.3 Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Eli Lilly and Company Disease-Modifying Antirheumatic Drug Products Offered
10.10.5 Eli Lilly and Company Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Disease-Modifying Antirheumatic Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Disease-Modifying Antirheumatic Drug Industrial Chain Analysis
11.4 Disease-Modifying Antirheumatic Drug Market Dynamics
11.4.1 Disease-Modifying Antirheumatic Drug Industry Trends
11.4.2 Disease-Modifying Antirheumatic Drug Market Drivers
11.4.3 Disease-Modifying Antirheumatic Drug Market Challenges
11.4.4 Disease-Modifying Antirheumatic Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Disease-Modifying Antirheumatic Drug Distributors
12.3 Disease-Modifying Antirheumatic Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Non-Steroidal Anti-Inflammatory Drugs
Table 2. Major Company of Steroidal Anti-Inflammatory Drugs
Table 3. Major Company of Slow Acting Drug
Table 4. Major Company of Immunological Preparation
Table 5. Global Disease-Modifying Antirheumatic Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Disease-Modifying Antirheumatic Drug Sales by Type (2024-2024) & (MT)
Table 7. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Disease-Modifying Antirheumatic Drug Sales by Type (2024-2024) & (US& Million)
Table 9. Global Disease-Modifying Antirheumatic Drug Market Share in Value by Type (2024-2024)
Table 10. Global Disease-Modifying Antirheumatic Drug Price by Type (2024-2024) & (USD/MT)
Table 11. Global Disease-Modifying Antirheumatic Drug Sales by Type (2024-2034) & (MT)
Table 12. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Disease-Modifying Antirheumatic Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Disease-Modifying Antirheumatic Drug Price by Type (2024-2034) & (USD/MT)
Table 16. North America Disease-Modifying Antirheumatic Drug Sales by Type (2024-2024) & (MT)
Table 17. North America Disease-Modifying Antirheumatic Drug Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Disease-Modifying Antirheumatic Drug Sales (MT) by Type (2024-2024)
Table 19. Europe Disease-Modifying Antirheumatic Drug Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales (MT) by Type (2024-2024)
Table 21. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Disease-Modifying Antirheumatic Drug Sales (MT) by Type (2024-2024)
Table 23. Latin America Disease-Modifying Antirheumatic Drug Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales (MT) by Type (2024-2024)
Table 25. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Disease-Modifying Antirheumatic Drug Sales by Company (2024-2024) & (MT)
Table 27. Global Disease-Modifying Antirheumatic Drug Sales Share by Company (2024-2024)
Table 28. Global Disease-Modifying Antirheumatic Drug Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Disease-Modifying Antirheumatic Drug Revenue Share by Company (2024-2024)
Table 30. Global Market Disease-Modifying Antirheumatic Drug Price by Company (2024-2024) & (USD/MT)
Table 31. Global Disease-Modifying Antirheumatic Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Disease-Modifying Antirheumatic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Disease-Modifying Antirheumatic Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Disease-Modifying Antirheumatic Drug Market
Table 35. Key Manufacturers Disease-Modifying Antirheumatic Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Disease-Modifying Antirheumatic Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Disease-Modifying Antirheumatic Drug Sales by Region (2024-2024) & (MT)
Table 39. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Disease-Modifying Antirheumatic Drug Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Region (2024-2024)
Table 42. Global Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2024)
Table 43. Global Disease-Modifying Antirheumatic Drug Sales by Region (2024-2034) & (MT)
Table 44. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Disease-Modifying Antirheumatic Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 48. Global Disease-Modifying Antirheumatic Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) & (MT)
Table 50. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Application (2024-2024)
Table 53. Global Disease-Modifying Antirheumatic Drug Price by Application (2024-2024) & (USD/MT)
Table 54. Global Disease-Modifying Antirheumatic Drug Sales by Application (2024-2034) & (MT)
Table 55. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Disease-Modifying Antirheumatic Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Disease-Modifying Antirheumatic Drug Price by Application (2024-2034) & (USD/MT)
Table 59. North America Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) (MT)
Table 60. North America Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) (MT)
Table 62. Europe Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) (MT)
Table 64. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) (MT)
Table 66. Latin America Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) (MT)
Table 68. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Disease-Modifying Antirheumatic Drug Sales by Country (2024-2024) & (MT)
Table 70. North America Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Disease-Modifying Antirheumatic Drug Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Country (2024-2024)
Table 73. North America Disease-Modifying Antirheumatic Drug Sales by Country (2024-2034) & (MT)
Table 74. North America Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Disease-Modifying Antirheumatic Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Disease-Modifying Antirheumatic Drug Sales by Country (2024-2024) & (MT)
Table 78. Europe Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Disease-Modifying Antirheumatic Drug Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Disease-Modifying Antirheumatic Drug Sales by Country (2024-2034) & (MT)
Table 82. Europe Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Disease-Modifying Antirheumatic Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales by Region (2024-2024) & (MT)
Table 86. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales by Region (2024-2034) & (MT)
Table 90. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Disease-Modifying Antirheumatic Drug Sales by Country (2024-2024) & (MT)
Table 94. Latin America Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Disease-Modifying Antirheumatic Drug Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Disease-Modifying Antirheumatic Drug Sales by Country (2024-2034) & (MT)
Table 98. Latin America Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Disease-Modifying Antirheumatic Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales by Country (2024-2024) & (MT)
Table 102. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales by Country (2024-2034) & (MT)
Table 106. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Country (2024-2034)
Table 109. AbbVie Company Information
Table 110. AbbVie Introduction and Business Overview
Table 111. AbbVie Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2024-2024)
Table 112. AbbVie Disease-Modifying Antirheumatic Drug Product
Table 113. AbbVie Recent Development
Table 114. Amgen Company Information
Table 115. Amgen Introduction and Business Overview
Table 116. Amgen Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2024-2024)
Table 117. Amgen Disease-Modifying Antirheumatic Drug Product
Table 118. Amgen Recent Development
Table 119. Pfizer Company Information
Table 120. Pfizer Introduction and Business Overview
Table 121. Pfizer Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2024-2024)
Table 122. Pfizer Disease-Modifying Antirheumatic Drug Product
Table 123. Pfizer Recent Development
Table 124. Roche Holding AG Company Information
Table 125. Roche Holding AG Introduction and Business Overview
Table 126. Roche Holding AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2024-2024)
Table 127. Roche Holding AG Disease-Modifying Antirheumatic Drug Product
Table 128. Roche Holding AG Recent Development
Table 129. Novartis International AG Company Information
Table 130. Novartis International AG Introduction and Business Overview
Table 131. Novartis International AG Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2024-2024)
Table 132. Novartis International AG Disease-Modifying Antirheumatic Drug Product
Table 133. Novartis International AG Recent Development
Table 134. Johnson & Johnson Company Information
Table 135. Johnson & Johnson Introduction and Business Overview
Table 136. Johnson & Johnson Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2024-2024)
Table 137. Johnson & Johnson Disease-Modifying Antirheumatic Drug Product
Table 138. Johnson & Johnson Recent Development
Table 139. Bristol-Myers Squibb Company Information
Table 140. Bristol-Myers Squibb Introduction and Business Overview
Table 141. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2024-2024)
Table 142. Bristol-Myers Squibb Disease-Modifying Antirheumatic Drug Product
Table 143. Bristol-Myers Squibb Recent Development
Table 144. Merck Company Information
Table 145. Merck Introduction and Business Overview
Table 146. Merck Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2024-2024)
Table 147. Merck Disease-Modifying Antirheumatic Drug Product
Table 148. Merck Recent Development
Table 149. UCB S.A. Company Information
Table 150. UCB S.A. Introduction and Business Overview
Table 151. UCB S.A. Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2024-2024)
Table 152. UCB S.A. Disease-Modifying Antirheumatic Drug Product
Table 153. UCB S.A. Recent Development
Table 154. Eli Lilly and Company Company Information
Table 155. Eli Lilly and Company Introduction and Business Overview
Table 156. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2024-2024)
Table 157. Eli Lilly and Company Disease-Modifying Antirheumatic Drug Product
Table 158. Eli Lilly and Company Recent Development
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Disease-Modifying Antirheumatic Drug Market Trends
Table 162. Disease-Modifying Antirheumatic Drug Market Drivers
Table 163. Disease-Modifying Antirheumatic Drug Market Challenges
Table 164. Disease-Modifying Antirheumatic Drug Market Restraints
Table 165. Disease-Modifying Antirheumatic Drug Distributors List
Table 166. Disease-Modifying Antirheumatic Drug Downstream Customers
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Disease-Modifying Antirheumatic Drug Product Picture
Figure 2. Global Disease-Modifying Antirheumatic Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Disease-Modifying Antirheumatic Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Disease-Modifying Antirheumatic Drug Sales Status and Outlook (2024-2034) & (MT)
Figure 5. Product Picture of Non-Steroidal Anti-Inflammatory Drugs
Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs Sales YoY Growth (2024-2034) & (MT)
Figure 7. Product Picture of Steroidal Anti-Inflammatory Drugs
Figure 8. Global Steroidal Anti-Inflammatory Drugs Sales YoY Growth (2024-2034) & (MT)
Figure 9. Product Picture of Slow Acting Drug
Figure 10. Global Slow Acting Drug Sales YoY Growth (2024-2034) & (MT)
Figure 11. Product Picture of Immunological Preparation
Figure 12. Global Immunological Preparation Sales YoY Growth (2024-2034) & (MT)
Figure 13. Global Disease-Modifying Antirheumatic Drug Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Disease-Modifying Antirheumatic Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Disease-Modifying Antirheumatic Drug Revenue in 2022
Figure 27. Disease-Modifying Antirheumatic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Pharmaceutical Industry
Figure 29. Global Pharmaceutical Industry Sales YoY Growth (2024-2034) & (MT)
Figure 30. Product Picture of Hospital and Clinic
Figure 31. Global Hospital and Clinic Sales YoY Growth (2024-2034) & (MT)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2024-2034) & (MT)
Figure 34. Global Disease-Modifying Antirheumatic Drug Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Disease-Modifying Antirheumatic Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Disease-Modifying Antirheumatic Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Disease-Modifying Antirheumatic Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Disease-Modifying Antirheumatic Drug Manufacturing Cost Structure
Figure 47. Disease-Modifying Antirheumatic Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries